1. Home
  2. MGTX vs IMTX Comparison

MGTX vs IMTX Comparison

Compare MGTX & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGTX
  • IMTX
  • Stock Information
  • Founded
  • MGTX 2015
  • IMTX N/A
  • Country
  • MGTX United States
  • IMTX Germany
  • Employees
  • MGTX N/A
  • IMTX N/A
  • Industry
  • MGTX Biotechnology: Biological Products (No Diagnostic Substances)
  • IMTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MGTX Health Care
  • IMTX Health Care
  • Exchange
  • MGTX Nasdaq
  • IMTX Nasdaq
  • Market Cap
  • MGTX 622.0M
  • IMTX 653.9M
  • IPO Year
  • MGTX N/A
  • IMTX N/A
  • Fundamental
  • Price
  • MGTX $7.65
  • IMTX $6.48
  • Analyst Decision
  • MGTX Strong Buy
  • IMTX Strong Buy
  • Analyst Count
  • MGTX 2
  • IMTX 4
  • Target Price
  • MGTX $24.00
  • IMTX $14.67
  • AVG Volume (30 Days)
  • MGTX 691.3K
  • IMTX 400.5K
  • Earning Date
  • MGTX 08-11-2025
  • IMTX 08-12-2025
  • Dividend Yield
  • MGTX N/A
  • IMTX N/A
  • EPS Growth
  • MGTX N/A
  • IMTX N/A
  • EPS
  • MGTX N/A
  • IMTX N/A
  • Revenue
  • MGTX $34,508,000.00
  • IMTX $155,801,989.00
  • Revenue This Year
  • MGTX $228.65
  • IMTX N/A
  • Revenue Next Year
  • MGTX $145.06
  • IMTX $1.92
  • P/E Ratio
  • MGTX N/A
  • IMTX N/A
  • Revenue Growth
  • MGTX 203.23
  • IMTX 93.56
  • 52 Week Low
  • MGTX $3.85
  • IMTX $3.30
  • 52 Week High
  • MGTX $8.98
  • IMTX $13.09
  • Technical
  • Relative Strength Index (RSI)
  • MGTX 46.02
  • IMTX 60.48
  • Support Level
  • MGTX $8.32
  • IMTX $6.44
  • Resistance Level
  • MGTX $8.31
  • IMTX $6.80
  • Average True Range (ATR)
  • MGTX 0.39
  • IMTX 0.32
  • MACD
  • MGTX -0.19
  • IMTX 0.02
  • Stochastic Oscillator
  • MGTX 13.36
  • IMTX 70.72

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

About IMTX Immatics N.V.

Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Share on Social Networks: